Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiracoxib extension in knee osteoarthritis
NCT00476034Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2003
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of lumiracoxib in osteoarthritis (OA), sponsored by Novartis. Started Dec 2003; status: completed.
02
Drugs
lumiracoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00476034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476034.